Skip to main content

Table 2 Cycle outcome characteristics for Cohorts I, II and III in age categories

From: Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH

Ages (years) <36 36–38 39–40 41–42 ≥43
COHORT I (n = 1247)
 Cycles (n) 432 174 162 183 296
 Embryos (n) 7.5 ± 5.1 3.7 ± 2.9 3.7 ± 2.9 3.3 ± 2.4 3.1 ± 2.2
 Pregnancies
  n 203 49 40 32 22
  % 47.0 28.2 24.7 17.5 7.4
 Live births
  n 173 34 29 18 10
  % 40.0 19.5 17.9 9.8 3.4
 Miscarriages
  n 30 15 11 14 12
  % 14.8 30.6 27.8 43.8 54.6
COHORT II (n = 1514)
 Cycles (n) 303 234 239 259 479
 FSH (mIU/mL) 11.8 ± 12.7 15.0 ± 14.1 15.5 ± 13.2 14.7 ± 14.2 18.0 ± 16.9
 Pregnancies
  n 101 50 40 32 23
  % 33.3 21.4 16.7 12.4 4.8
 Live births
  n 86 35 29 18 10
  % 28.4 15.0 12.1 6.9 2.1
 Miscarriages
  n 15 15 11 14 13
  % 14.9 30.0 27.5 43.8 56.5
COHORT III (n = 632)
 Cycles (n) 127 87 103 109 206
 AMH (ng/mL) 2.3 ± 3.3 1.1 ± 1.9 0.7 ± 1.0 0.6 ± 1.1 0.7 ± 0.7
 Pregnancies
  n 45 16 16 14 15
  % 35.4 18.4 15.5 12.8 7.3
 Live births
  n 37 11 13 7 5
  % 29.1 12.6 12.6 6.4 2.4
 Miscarriages
  n 8 5 3 7 10
  % 17.8 31.2 18.8 50.0 66.7